Early detection of kidney disease is now possible with a simple blood test, as a protein-based risk score can predict kidney ...

By analyzing protein markers, a blood test identifies those most likely to develop kidney failure years ahead, enabling ...

The investigators explained that GLP-1 receptor agonists appear to be able to help resolve MASH without worsening fibrosis. Those findings have been confirmed in mouse models and in multiple studies ...

It might not be too late to invest in this company.

Perha Pharmaceuticals has discovered new pyrazolo[1,5-a]pyrimidine derivatives acting as adenosine A3 receptor antagonists potentially useful for the treatment of ulcerative colitis, atopic dermatitis ...

VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney ...

Fibrosis, a characteristic of all chronic kidney diseases (CKD), is now recognized to be an independent predictor of disease ...

Trials of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, are documenting its direct kidney effects and broad benefits for diabetic kidney disease.

WASHINGTON — As her son prepared for yet another major surgery in Georgia, Sherry Petty said something she had been holding onto for years. "Your whole life, I was never able to do anything to help ...